- Home
- HSON vs DARE Comparison
HSON vs DARE Comparison
Compare HSON & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSON
- DARE
- Stock Information
- Founded
- HSON 1999
- DARE N/A
- Country
- HSON United States
- DARE United States
- Employees
- HSON N/A
- DARE N/A
- Industry
- HSON Professional Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- HSON Consumer Discretionary
- DARE Health Care
- Exchange
- HSON Nasdaq
- DARE Nasdaq
- Market Cap
- HSON N/A
- DARE 29.2M
- IPO Year
- HSON N/A
- DARE N/A
- Fundamental
- Price
- HSON $15.20
- DARE $3.55
- Analyst Decision
- HSON
- DARE Strong Buy
- Analyst Count
- HSON 0
- DARE 4
- Target Price
- HSON N/A
- DARE $40.33
- AVG Volume (30 Days)
- HSON 8.3K
- DARE 31.7K
- Earning Date
- HSON 11-07-2024
- DARE 11-07-2024
- Dividend Yield
- HSON N/A
- DARE N/A
- EPS Growth
- HSON N/A
- DARE N/A
- EPS
- HSON N/A
- DARE N/A
- Revenue
- HSON $142,972,000.00
- DARE $2,839,625.00
- Revenue This Year
- HSON $0.39
- DARE $388.48
- Revenue Next Year
- HSON $20.49
- DARE $67.37
- P/E Ratio
- HSON N/A
- DARE N/A
- Revenue Growth
- HSON N/A
- DARE N/A
- 52 Week Low
- HSON $13.38
- DARE $3.05
- 52 Week High
- HSON $19.70
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- HSON 38.11
- DARE 60.74
- Support Level
- HSON $15.18
- DARE $3.30
- Resistance Level
- HSON $16.09
- DARE $3.47
- Average True Range (ATR)
- HSON 0.26
- DARE 0.18
- MACD
- HSON 0.00
- DARE 0.05
- Stochastic Oscillator
- HSON 1.82
- DARE 65.11
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.